Journal Mobile Options
Table of Contents
Vol. 198, No. 3, 1999
Issue release date: 1999
Dermatology 1999;198:310–313
(DOI:10.1159/000018139)

Epidermolysis bullosa acquisita with Combined Features of Bullous Pemphigoid and Cicatricial Pemphigoid

Wieme N. · Lambert J. · Moerman M. · Geerts M.L. · Temmerman L. · Naeyaert J.M.
Departments of aDermatology, bOtorhinolaryngology, University of Gent, Belgium

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Epidermolysis bullosa acquisita (EBA) is an acquired subepidermal blistering disease associated with autoantibodies against type VII collagen. The classical or mechanobullous form of EBA is characterized by skin fragility, trauma-induced blisters and erosions with mild mucous membrane involvement and healing with scars. Furthermore, bullous-pemphigoid-like and cicatricial pemphigoid-like features have been described. We report a patient who developed a bullous skin disease with upper airway obstruction requiring tracheotomy. The diagnosis of EBA was established by immunoblot, showing a band at 290 kD (collagen VII), and NaCl-split skin immunofluorescence (IgG deposition at the floor of the split). This case presented with clinical features of both bullous pemphigoid and cicatricial pemphigoid which to our knowledge is the first report of such a combination in EBA. The patient also presented tracheal involvement that has never been described either.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Tatnall FM, Whitehead PC, Black MM, Wojnarowska F, Leigh IM: Identification of the EBA antigen by LH 7.2 monoclonal antibody: Use in diagnosis. Br J Dermatol 1989;120: 533–539.

    External Resources

  2. Elliot GI: Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895;13:10.
  3. Gammon WR, Briggaman RA: Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: Diseases of autoimmunity to type VII collagen. Derm Clin 1993;11:3:535– 547.
  4. Gammon WR, Briggaman RA, Wheeler CE Jr: Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 1982;7:382–387.

    External Resources

  5. Dahl MGC: Epidermolysis bullosa acquisita – A sign of cicatricial pemphigoid? Br J Dermatol 1979;101:474–484.
  6. Joly P, Ruto F, Thomine E, Delpech A, Balguerie X, Tron F, Lauret P: Brunsting-Perry cicatricial bullous pemphigoid: A clinical variant of localized acquired epidermolysis bullosa? J Am Acad Dermatol 1993;28:89–92.
  7. Yoon J, Moon TK, Lee KH, Kim SC: Fatal vascular involvement in systemic lupus erythematosus following epidermolysis bullosa acquisita. Acta Derm Venereol 1995;75:143–146.
  8. Schattenkirchner S, Lemann M, Prost C, Caux F, Guigui B, Cadot M, Bertheau P, Grateau C, Heller M: Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn’s disease. Am J Gastroenterol 1996;91: 1657–1659.
  9. Muller SA, Sams WM, Dobson RL: Amyloidosis masquerading as epidermolysis bullosa acquisita. Arch Dermatol 1969;99:739–747.
  10. Kirtschig G, Chow ETY, Venning VA, Wojnarowska FT: Acquired subepidermal bullous diseases associated with psoriasis: A clinical, immunopathological and immunogenetic study. Br J Dermatol 1996;135:738–745.
  11. Roenigk HJ, Ryan J, Bergfeld W: Epidermolysis bullosa acquisita: Report of three cases and review of all published cases. Arch Dermatol 1971;103:1–10.
  12. Almeyda J: Epidermolysis bullosa associated with neoplasm of the bronchus. Br J Dermatol 1972;87:70–71.

    External Resources

  13. Callot-Mellot C, Bodemer C, Caux F, Bourgault-Villada I, Fraitag S, Goudié G, Heller M, de Prost Y, Prost C: Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997; 133:1122–1126.
  14. Edwards S, Wakelin SH, Wojnarowska F, Marsden RA, Kirtschig G, Bhogal B, Black MM: Bullous pemphigoid and epidermolysis bullosa acquisita: Presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 1998;15:184–190.
  15. Ghohestani R, Kanitakis J, Nicolas JF, Cozzani E, Claudy A: Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996;135:74–79.
  16. Stewart MI, Woodley DT, Briggaman RA: Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol 1991;127:373–377.
  17. Richter BJ, McNutt NS: The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979;115:1325–1328.
  18. Clement M, Ratnesar P, Thirumoorthy T, McGrath J, Black MM: Epidermolysis bullosa acquisita: A case with upper airway obstruction requiring tracheostomy and responding to cyclosporin. Clin Exp Dermatol 1993;18:548– 551.
  19. Hester JR, Arnstein DP, Woodley D: Laryngeal manifestations of epidermolysis bullosa acquisita. Arch Otolaryngol Head Neck Surg 1995; 121:1042–1044.
  20. Zambruno G, Manca V, Kanitakis J, Cozzani E, Nicolas J-F, Giannetti A: Linear IgA bullous dermatosis with autoantibodies to a 290-kD antigen of anchoring fibrils. J Am Acad Dermatol 1994;31:884–888.

    External Resources

  21. Caux F, Kirtschig G, Lemarchand-Venencie F, Venencie P-Y, Hoang-Xuan T, Robin H, Dubertret L, Prost C: IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol 1997;137:270–275.
  22. Gammon WR, Fine JD, Forbes M, Briggaman RA: Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992;27:79–87.
  23. Chen M, Chan LS, Cai X, OíToole EA, Sample JC, Woodley DT: Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108:68–72.
  24. Tanaka H, Ishida-Yamamoto A, Hashimoto T, Hiramoto K, Harada T, Kawachi Y, Shimizu H, Tanaka T, Kishiyama K, Hopfner B, Takahashi H, Iizuka H, Bruckner-Tuderman L: A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 1997; 77:623–632.
  25. Gammon WR, Inman AO III, Wheeler CE Jr: Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: Demonstration by leucocytic attachment and organ culture methods. J Invest Dermatol 1984;83:57–61.

    External Resources

  26. Gammon WR, Yancey KB, Mangum KL, Hendrix JD, Hammer CH: Generation of C5-dependent bioactivity of tissue-bound anti-BMZ autoantibodies. J Invest Dermatol 1989;93: 195–200.

    External Resources

  27. Gammon WR, Briggaman RA: Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993;11: 535–547.
  28. Borradori L, Caldwell MJB, Briggaman RA, Burr CE, Gammon WR, James WD, Yancey KB: Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131: 590–595.
  29. Mohr C, Sunderkotter C, Hildebrand A: Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol 1995;132:824–826.
  30. Kofler H, Wambacher-Gasser B, Topar G, Weinlich G, Schuler G, Hintner H, Romani N, Fritsch P: Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 1997;36:331– 335.
  31. Miller JL, Stricklin GP, Fine JD, King LE, Del Carmen Arzubiaga, Ellis DL: Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995;133:467–471.
  32. Cunningham BB, Kirchman TTT, Woodley D: Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996;34:781–784.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00